Nidan Laboratories And Healthcare Ltd.
Snapshot View

58.70 -0.65 ▼-1.1%

07 October 2022, 11:42:46 AM
Volume: 1,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.nidanhealthcare.co.in
Market Cap 82.15 Cr.
Enterprise Value(EV) 111.70 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 1.92 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 30.85 Trailing Twelve Months Ending 2022-03
Industry PE 50.40 Trailing Twelve Months Ending 2022-03
Book Value / Share 45.56 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.30 Calculated using Price: 59.10
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.39 Cr. 13,900,000 Shares
FaceValue 10
Company Profile
The company offers diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.10%
1 Week
-3.45%
1 Month
-19.53%
3 Month
+70.14%
6 Month
+27.19%
1 Year
2 Year
5 Year
10 Year
3 years 2019-03 2020-03 2021-03
Return on Equity (%) 2.17 6.70 18.90
Return on Capital Employed (%) 11.71 10.15 14.21
Return on Assets (%) 0.52 1.63 4.74

Balance Sheet View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 10 11 13
Non Curr. Liab. 32 34 36
Curr. Liab. 1 0 3
Minority Int.
Equity & Liab. 43 45 52
Non Curr. Assets 24 21 21
Curr. Assets 19 24 32
Misc. Exp. not W/O
Total Assets 43 45 52

Profit Loss View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 20 21 20
Other Income 0 0 1
Total Income 20 21 21
Total Expenditure -12 -14 -11
PBIDT 8 8 10
Interest -5 -4 -3
Depreciation -3 -3 -3
Taxation -1
Exceptional Items
PAT 0 1 2
Adjusted EPS 0 1 2

Cash Flow View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 9 5 4
Cash Fr. Inv. 1 0 -3
Cash Fr. Finan. -6 -2 -1
Net Change 4 3 0
Cash & Cash Eqvt 4 7 7

Shareholding Pattern View Details >>

1 Qtrs 2022-03 (%)
Promoter 71.22
Public 28.79
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Announcements View Details >>

No Corporate Announcement found.

Technical Scans View Details >>

Thu, 06 Oct 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Decrease 1 Month High Decrease 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 951.95 -0.2%
Divi's Laboratories Ltd. 99,171.10 3,727.80 -0.1%
Cipla Ltd. 91,534.16 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. 54,354.34 1,599.90 -0.3%
Zydus Lifesciences Ltd. 42,831.42 424.30 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 951.95 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,727.80 -0.1%
Cipla Ltd. Consolidated 2022-06 36.78 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,599.90 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 424.30 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 951.95 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,727.80 -0.1%
Cipla Ltd. Consolidated 2022-06 4.26 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,599.90 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 424.30 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 951.95 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,727.80 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,599.90 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 424.30 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 951.95 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,727.80 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,599.90 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 424.30 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 951.95 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,727.80 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,599.90 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 424.30 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 951.95 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,727.80 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,599.90 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 424.30 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 951.95 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,727.80 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,137.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,384.65 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,367.90 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,599.90 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 424.30 +0.2%

FAQ's On Nidan Laboratories And Healthcare Ltd.

What is Nidan Labs. & Health share price?

Can I buy Nidan Labs. & Health shares now?

What is the Market Cap of Nidan Labs. & Health?

What are the key metrics to analyse Nidan Labs. & Health?

What is the 52 Week High and Low of Nidan Labs. & Health?

What is the trend of Nidan Labs. & Health share price?